Cyalume Technologies Holdings, Inc. (OTCBB: CYLU) ("the Company" or "Cyalume") today reported its financial results for the second quarter ended June 30, 2012.

Selected Financial Data:

$ in thousands

(except per share data)

   3 Months Ended  

Change**

   6 Months Ended  

Change**

  6/30/12   6/30/11     6/30/12   6/30/11  
Revenues   $ 8,923   $ 8,680   2.8%   $ 16,917   $ 17,754   (4.7)%
Gross profit   $ 3,890   $ 4,251   (8.5)%   $ 7,519   $ 8,770   (14.3)%
Gross margin     43.6%     49.0%   (540) bps     44.4%     49.4%   (500) bps
Net income (loss)   $ (367)   $ 944   NM*   $ (1,356)   $ 1,216   NM*
Diluted net income (loss) per share   $ (0.02)   $ 0.06   NM*   $ (0.07)   $ 0.07   NM*
Adjusted EBITDA   $ 1,016   $ 1,960   (48.2)%   $ 2,186   $ 4,200   (48.0)%

*NM - Not meaningful

 

Adjusted EBITDA is an important measure because it presents a view of our performance on an ongoing basis without regard to capital structures, capital investments cycles and corresponding ages of related assets among comparable companies. A more detailed description of Adjusted EBITDA and reconciliation to GAAP net income (loss) is contained later in this release.

 

Revenues by Product Category:

($ in millions)   3 Months Ended  

Change**

   6 Months Ended  

Change**

  6/30/12   6/30/11     6/30/12   6/30/11  
Military (non-ammunition)   $ 5.1   $ 6.5   $ (1.4)   $ 9.6   $ 13.0   $ (3.4)
Ammunition   $ 0.8   $ 1.1   $ (0.3)   $ 1.6   $ 2.8   $ (1.2)
Law enforcement / commercial public safety   $ 0.9   $ 1.1   $ (0.2)   $ 1.9   $ 2.0   $ (0.1)
Specialty products   $ 2.1     -   $ 2.1   $ 3.8     -   $ 3.8
Total   $ 8.9   $ 8.7   $ 0.2   $ 16.9   $ 17.8   $ (0.9)

** Numbers may not add exactly due to rounding

 

Cyalume's President & CEO, Zivi Nedivi noted, "Although 2012 second quarter revenues increased slightly as compared to the same period of last year due to the inclusion of specialty products, our overall results continued to be adversely affected by the uncertainty of prospective military budgets in the U.S., combined with the drawdown/reassignment of military troops in Iraq and Afghanistan. We expect military (non-ammunition) chemical light sales to remain at depressed levels until these budget uncertainties are resolved. However, as we previously announced, we have taken several steps to change the Company's direction and quickly turn around our business. We are making good progress with our new initiatives and we expect to see positive results by 2012 year-end."

Conference Call

Cyalume's President & CEO, Zivi Nedivi, and CFO, Michael Bielonko will host a conference call on Friday, August 10, 2012 at 10:00 am ET to discuss these results as well as recent corporate developments. After opening remarks, there will be a question and answer period. Interested parties may participate in the call by dialing (201) 493-6739. Please call in 10 minutes before the conference call is scheduled to begin and ask for the Cyalume call. Questions may be asked during the live call, or alternatively, you may e-mail questions in advance to lcati@equityny.com.

The conference call will also be broadcast live over the Internet. To listen to the live call, please go to www.cyalume.com click on the Investors section, then to the Events and Presentations where the conference call is posted. Please go to the website 15 minutes early to download and install any necessary audio software. If you are unable to listen live, the conference call will be archived and can be accessed for approximately 90 days. We suggest listeners use Microsoft Explorer as their browser.

About Cyalume Technologies Holdings, Inc.

Cyalume designs and manufactures non-pyrotechnic tactical products and training solutions for the world's militaries and law enforcement agencies, as well as for certain safety markets. Cyalume is the exclusive supplier to the U.S. and NATO-country militaries for all of their chemical light needs and operates manufacturing facilities in the U.S. and France. Through its subsidiary Cyalume Specialty Products, Cyalume also manufactures specialty chemical components for various markets. The Company has a strategic partnership with Rheinmetall Waffe Munition, GmbH to provide the U.S. Marines with the only non-pyrotechnic projectile used by the military.

Forward-Looking Statements

This press release and the accompanying scheduled investor conference call include forward-looking statements concerning sales and operating earnings. These forward-looking statements are based upon management's expectations and beliefs concerning future events. Forward-looking statements are necessarily subject to risks, uncertainties and other factors, many of which are outside the control of the Company and which could cause actual results to differ materially from such statements. These risks and uncertainties include, but are not limited to: the effect of regional and global economic and industrial market conditions including our expectations concerning their impact on the markets we serve; the effect of conditions in the financial and credit markets and their impact on the Company and our customers and suppliers; the impact of the Company's cost reduction initiatives; the Company's ability to execute its business plan to meet its sales, operating income, cash flow and capital expenditure guidance; the impact on the Company's gross profit margins as a result of changes in product mix; the Company's vulnerability to industry conditions and competition; the effect of any interruption in the Company's supply of raw materials or a substantial increase in the price of raw materials; ongoing capital expenditures and investment in research and development; compliance with any changes in government regulations and environmental and health and safety laws; the effect on the Company's international operations of unexpected changes in legal and regulatory requirements, export restrictions, currency controls, tariffs and other trade barriers, difficulties in staffing and managing foreign operations, political and economic instability, difficulty in accounts receivable collection and potentially adverse tax consequences; the effect of foreign currency exchange rates as the Company's non-U.S. sales continue to increase; reliance for a significant portion of the Company's total revenues on a limited number of large organizations and the continuity of business relationships with major customers; the loss of key personnel; the nature and extent of military operations being conducted by customers.

Actual results and events may differ significantly from those projected in the forward-looking statements. Reference is made to Cyalume's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K, its quarterly reports on Form 10-Q, and other periodic filings, for a description of the foregoing and other factors that could cause actual results to differ materially from those in the forward-looking statements. Any forward-looking statement speaks only as of the date on which such statement is made, and the Company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

 

Cyalume Technologies Holdings, Inc.

Consolidated Statements of Operations

(in thousands, except per share data)

   

 

   
For the Three For the Three For the Six For the Six
Months Ended Months Ended Months Ended Months Ended
June 30, June 30, June 30, June 30,
2012 2011 2012 2011
Revenues $ 8,923 $ 8,680 $ 16,917 $ 17,754
Cost of goods sold 5,033 4,429 9,398 8,984
Gross profit 3,890 4,251 7,519 8,770
 
Other expenses:
Sales and marketing 1,725 1,136 2,967 2,198
General and administrative 1,476 1,620 3,426 3,054
Research and development 377 439 983 938
Interest expense, net 571 609 1,116 1,208
Interest expense - related party 6 17 16 34
Amortization of intangible assets 477 403 954 805
Change in fair value of contingent consideration (95 ) 0 222 0
Other, net (118 ) (269 ) (114 ) (216 )
Total other expenses 4,419 3,955 9,570 8,021
 
Income (loss) before income taxes (529 ) 296 (2,051 ) 749
Benefit from income taxes (162 ) (648 ) (695 ) (467 )
Net income (loss) (367 ) 944 (1,356 ) 1,216
 
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments (367 ) 135 (184 ) 572
Unrealized gain (loss) on cash flow hedges, net of taxes of $(14) and $17, respectively 24 (30 ) 33 4
Other comprehensive income (loss) (343 ) 105 (151 ) 576
Comprehensive income (loss) $ (710 ) $ 1,049 $ (1,507 ) 1,792
 
Net income (loss) per common share:
Basic $ (.02 ) $ .06 $ (.07 ) $ .08
Diluted $ (.02 ) $ .06 $ (.07 ) $ .07
 
Weighted average shares used to compute net income (loss) per common share:
Basic 18,192,884 16,507,117 18,182,789 16,126,735
Diluted 18,192,884 19,518,504 18,182,789 16,858,727
 
   

Cyalume Technologies Holdings, Inc.

Consolidated Balance Sheets

(in thousands, except per share data)

 

 

June 30,

2012

(unaudited)

December 31,

2011

Assets
Current assets:
Cash $ 1,450 $ 2,951
Accounts receivable, net of allowance for doubtful accounts of $189 and $206, respectively 4,408 3,339
Inventories 12,100 11,393
Income taxes refundable 190 38
Deferred income taxes 390 386
Prepaid expenses and other current assets 534 559
Total current assets 19,072 18,666
 
Property, plant and equipment, net 9,791 10,417
Goodwill 55,431 55,329
Other intangible assets, net 21,200 22,007
Due from related party 3,766 3,721
Restricted cash 0 600
Other noncurrent assets 93 154
Total assets $ 109,353 $ 110,894
 
Liabilities and Stockholders' Equity
Current liabilities:
Current portion of notes payable $ 1,511 $ 1,592
Line of credit 900 0
Accounts payable 3,842 1,948
Accrued expenses 2,105 2,179
Note payable to related party 0 250
Current portion of capital lease obligation 26 43
Total current liabilities 8,384 6,012
 
Notes payable, net of current portion 17,601 18,975
Line of credit due to related party 0 755
Deferred income taxes 6,305 7,145
Contingent consideration 4,087 3,699
Derivatives 223 273
Asset retirement obligation 180 175
Capital lease obligation, net of current portion 30 30
Contingent legal obligation 3,716 3,627
Total liabilities 40,526 40,691

 

Commitments and contingencies (Note 10)
 
Stockholders' equity
Preferred stock, $0.001 par value; 1,000,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.001 par value; 50,000,000 shares authorized; 18,275,093 and 18,311,228 issued and outstanding, respectively 18 18
Additional paid-in capital 100,465 100,334
Accumulated deficit (30,809 ) (29,453 )
Accumulated other comprehensive loss (847 ) (696 )
Total stockholders' equity 68,827 70,203
Total liabilities and stockholders' equity $ 109,353 $ 110,894
 

Adjusted EBITDA (a Non-GAAP Financial Measure)

Cyalume defines Adjusted EBITDA as net income before interest expense, income taxes, depreciation, amortization, non-cash stock-based compensation, foreign currency gains or losses and one-time income or expense items. Management uses Adjusted EBITDA for establishing internal budgets, goals and certain performance bonuses. Internal financial reports including those provided to the Board of Directors, focus on Adjusted EBITDA. Since Adjusted EBITDA is not necessarily an indicator of overall cash flows of Cyalume, management reviews capital budgets and cash flow forecasts in parallel with Adjusted EBITDA analysis. Because Adjusted EBITDA eliminates interest expense, income taxes and depreciation, amortization, non-cash stock-based compensation, foreign currency gains or losses and one-time income or expense items, Cyalume considers this financial measure an important indicator of Cyalume's liquidity, operational strength and performance. Investors may find Adjusted EBITDA useful as it illustrates underlying operating trends in Cyalume's business.

In addition, components of Adjusted EBITDA are a key component in the determination of our compliance with certain covenants under our credit agreements. Adjusted EBITDA is not a measure of financial performance under GAAP. Adjusted EBITDA should not be considered in isolation, or as a substitute for net income, cash flows, or other consolidated income or cash flow data presented in accordance with GAAP or as a measure of our liquidity or financial condition. Because Adjusted EBITDA is not a measure determined in accordance with GAAP and is thus susceptible to varying calculations, Adjusted EBITDA as discussed may not be comparable to other similarly titled measures of other companies.

The use of Adjusted EBITDA as a supplemental liquidity measure is useful as it assists management in understanding and evaluating the Company's capacity, excluding the impact of interest, taxes, and non-cash depreciation and amortization charges, for servicing debt and other cash needs, prior to our consideration of the impacts of other potential sources and uses of cash, such as working capital items. Investors may find it useful for these purposes as well. Adjusted EBITDA should not be considered an alternative to, or more meaningful than, net cash provided by operating activities, as determined in accordance with GAAP, since it omits the impact of interest, taxes and changes in working capital that use or provide cash (such as receivables, payables and inventories) as well as the sources or uses of cash associated with changes in other balance sheet items (such as long-term loss accruals and deferred items). Because Adjusted EBITDA excludes depreciation and amortization, Adjusted EBITDA does not reflect any cash requirements for the replacement of the assets being depreciated and amortized, which assets will often have to be replaced in the future. Further, Adjusted EBITDA, because it also does not reflect the impact of debt service, income taxes, cash dividends, capital expenditures and other cash commitments, does not represent how much discretionary cash we have available for other purposes. Nonetheless, Adjusted EBITDA is a key measure expected by and useful to our investors, rating agencies and the banking community in the analysis of a Company's ability to service debt, fund capital expenditures and otherwise meet cash needs, respectively. Cyalume also evaluates Adjusted EBITDA because it is clear that movements in these non-GAAP measures impact the Company's ability to attract financing. Adjusted EBITDA, as calculated, may not be comparable to similarly titled measures reported by other companies.

             

Cyalume Technologies Holdings, Inc.

Reconciliation of Net Income to Adjusted EBITDA

(Unaudited, in thousands)

 
For the Three For the Three For the Six For the Six
Months Ended Months Ended Months Ended Months Ended
June 30, June 30, June 30, June 30,
2012 2011 2012 2011
 
Net Income $ (367 ) $ 944 $ (1,356 ) $ 1,216
 
Adjustments to arrive at EBITDA:
Interest expense, net 577 626 1,132 1,242
Provision for (benefit from) income taxes (162 ) (648 ) (695 ) (467 )
Depreciation 342 257 683 522
Amortization 477 403   954 805
 
EBITDA 867 1,582 718 3,318
 
Adjustments to arrive at Adjusted EBITDA:
Other one-time expenses (1) 149 378   1,468 882

Adjusted EBITDA

$ 1,016 $ 1,960 $ 2,186 $ 4,200
        (1)   Severance related, inventory step-up amortization, non-cash stock-based compensation, foreign exchange (gains)/losses, acquisition related costs and change in fair value of contingent consideration

Cyalume Technologies Holdings, Inc.
Michael Bielonko, 413-858-2500
Chief Financial Officer
www.cyalume.com
or
Investor Relations Counsel:
The Equity Group Inc.
Lena Cati, 212-836-9611
Linda Latman, 212-836-9609
www.theequitygroup.com